Immune system study for multiple lung nodules after surgery
Part of Cancer, Lungs & breathing clinical trials.
This study looks at the immune system using a special blood test to learn more about multiple lung nodules after surgery. It may help doctors better understand and monitor your condition over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had surgery to remove a lung nodule and still have other lung nodules that are being followed.
- You are having regular follow-up visits at the participating hospital and can give a blood sample along with your routine blood work.
- You do not have severe anemia, bleeding problems, or other conditions that make an extra blood draw unsafe.
- You are not currently on strong immune-suppressing medications that would affect the study results.
- You are willing to give written consent to use your blood sample for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from people who have had a lung nodule removed but still have other nodules. The goal is to find patterns in immune cells and past viral infections that might help doctors better monitor or predict how these remaining nodules behave.
This study follows people with a type of lung nodule called subsolid, which appears partly solid on CT scans. The goal is to watch how these nodules behave over time, which can help doctors learn more about them and improve care.
This study is collecting blood samples from people with lung nodules to help design a better test for lung cancer. It may help find cancer earlier without invasive procedures.
This trial is testing a new treatment using your own immune cells (called NK cells) to fight leftover high-risk lung nodules that cannot be surgically removed. It is for people who have already had some cancerous nodules removed and are looking for another option.
This study tests a blood test that helps doctors figure out if a lung nodule is likely to be cancer. The test may help avoid unnecessary procedures for people with suspicious but not clearly cancerous nodules.
This study looks for biological markers (special signs in your body) that could help doctors choose better immune-based treatments for non-small cell lung cancer. Researchers will study your tumor and blood to understand which patients might benefit most from immunotherapy.
Hear when a new Multiple Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.